These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15481510)

  • 21. Anemia in chronic kidney disease: causes, diagnosis, treatment.
    Nurko S
    Cleve Clin J Med; 2006 Mar; 73(3):289-97. PubMed ID: 16548452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA; Salim S; Mathew T
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional implications of recombinant human erythropoietin therapy in renal disease.
    Sanders HN; Rabb HA; Bittle P; Ramirez G
    J Am Diet Assoc; 1994 Sep; 94(9):1023-9. PubMed ID: 8071484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.
    Schröder CH;
    Pediatr Nephrol; 2003 Aug; 18(8):805-9. PubMed ID: 12750985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Back to the basics in iron management for the patient receiving epoetin therapy.
    Kirlin L
    ANNA J; 1991 Aug; 18(4):428. PubMed ID: 1872645
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
    Winearls CG
    Drugs; 1989 Sep; 38(3):342-5. PubMed ID: 2806134
    [No Abstract]   [Full Text] [Related]  

  • 28. [Erythropoiesis stimulating agents in clinical practice].
    Niemczyk L; Dębowska M
    Wiad Lek; 2014; 67(3):413-5. PubMed ID: 25782201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review of the scientific evidence of the efficiency of erythropoietin use].
    García-Altés A; Puig-Junoy J
    Med Clin (Barc); 2006 Sep; 127(11):415-20. PubMed ID: 17020686
    [No Abstract]   [Full Text] [Related]  

  • 31. Considerations for optimal iron use for anemia due to chronic kidney disease.
    Hudson JQ; Comstock TJ
    Clin Ther; 2001 Oct; 23(10):1637-71. PubMed ID: 11726002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
    Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
    J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaemia management in cardio renal disease.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate.
    Walker RG; Strippoli GF
    Lancet; 2007 Oct; 370(9596):1395-6. PubMed ID: 17950848
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythropoietin: from mountain top to bedside.
    Erslev AJ; Caro J
    Adv Exp Med Biol; 1989; 271():1-7. PubMed ID: 2486278
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 38. Anemia of chronic renal disease.
    Erslev AJ
    Arch Intern Med; 1970 Nov; 126(5):774-80. PubMed ID: 4920204
    [No Abstract]   [Full Text] [Related]  

  • 39. rHuEpo before dialysis and in dialysed patients.
    López-Gómez JM; Jofre R; Moreno F; Verde E; Valderràbano F
    Nephrol Dial Transplant; 1995; 10 Suppl 6():31-5. PubMed ID: 8524491
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.